This site is intended for healthcare professionals only

Glucose monitors to be made available to all type 1 diabetes patients

Written by: | Published:

A device similar to the one that will be prescribe A device similar to the one that will be prescribed

People with Type 1 diabetes across the country will be given from ‘life changing’ glucose monitors on the NHS, Simon Stevens has announced.

Mr Stevens, Chief Executive of NHS England, announced the measure to end the current variation patients in some parts of the country are facing to access Freestyle Libre, used by prime minister Theresa May, to coincide with World Diabetes Day. According to NHS England, the wearable sensor does away with the need for finger prick blood tests by relaying glucose levels to a smart phone or e-reader.

‘Increasingly the NHS is going to be offering patients this sort of technology to help them more easily manage their own long term health problem,’ said Mr Stevens. ‘In the NHS of the future, for many conditions you’re going to get NHS support direct from your smartphone or wearable device rather than having to trek to regular hospital outpatient appointments. Supporting people with modern tools to manage conditions such as Type 1 diabetes is about to become much more widespread. Innovations such as these also free up time and resources for the NHS as a whole.’

NHS England will make the device available on prescription for all patients who qualify for it in line with NHS clinical guidelines, from April 2019. These patients will be able to receive it on prescription from their local GP or diabetes team. The device will be funded for people with Type 1 diabetes from next year’s funding growth for local health groups which will allow access to flash monitoring throughout the country.

‘This is an exciting and welcome step forward as the aim is to have uniform prescribing policy across the NHS, irrespective of where someone with Type 1 diabetes lives,’ said Dr Partha Kar, Associate National Clinical Director for Diabetes at NHS England. ‘This will be based on previous national guidance issued- with the provision of updating it as further evidence accrue.’

What do you think? Leave a comment below or tweet your views to @IndyNurseMag

This material is protected by MA Healthcare Ltd copyright.
See Terms and Conditions.



Please view our Terms and Conditions before leaving a comment.

Change the CAPTCHA codeSpeak the CAPTCHA code

Read a free issue from Practice Nursing

Register to read a free issue from our sister publication, Practice Nursing.

Including articles on asthma, diabetes and more. Read your copy.


Sign up to the newsletter


Independent Nurse is the professional resource for primary care and community nurses, providing clinical articles for practice nurses and prescribers.


Subscribe to our newsletter and stay up to date with the latest nursing news.

Stay Connected

Stay social with Independent Nurse by following us on Twitter, liking us on Facebook or connecting on LinkedIn.


Need access to some of our older articles? You can view our archive, or alternatively contact us.

Contact Us

MA Healthcare Ltd.
St Jude's Church, Dulwich Road
London, SE24 0PB

Tel: +44 (0)20 7738 5454
Registered in England and Wales No. 01878373

Meet the team


Find out how to contribute to Independent Nurse here.